<DOC>
	<DOCNO>NCT01098708</DOCNO>
	<brief_summary>Many therapeutic trial DMD exclude non-ambulatory boy men . Rate progression non-ambulatory patient study consensus reach measure reliable reproducible . Furthermore , treatment trial would expect demonstrate improve function improvement quality life . Therefore , function , strength , quality life must understand standardize . While goal proposal standardize clinical outcome therapeutic trial , careful understanding progression DMD non ambulatory boy may also lead good medical treatment .</brief_summary>
	<brief_title>This Study Get More Information About Non Ambulatory Boys &amp; Men With Duchenne Muscular Dystrophy</brief_title>
	<detailed_description>For Non-ambulatory study , boys must unable walk without assistive device great equal one year . Age onset study non-ambulatory boy men : great equal 7 year age 22 year . Genetic biopsy confirmation dystrophinopathy clinical diagnosis DMD biopsy/genetic confirmation primary relative .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>1 . For Nonambulatory study , boys must unable walk without assistive device great equal one year . 2 . Age onset study nonambulatory boy men : great equal 7 year age 22 year . 3 . Genetic biopsy confirmation dystrophinopathy clinical diagnosis DMD biopsy/genetic confirmation primary relative . 1 . For Nonambulatory study , inability understand cooperate testing would exclude subject .</criteria>
	<gender>Male</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>DMD</keyword>
	<keyword>non ambulatory</keyword>
</DOC>